Net Cash Provided by (Used in) Financing Activities of BIOLARGO, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
BIOLARGO, INC. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • BIOLARGO, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $866,000, a 20% decline year-over-year.
  • BIOLARGO, INC. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $8,221,000, a 85% increase from 2024.
  • BIOLARGO, INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $4,438,000, a 4.7% decline from 2023.
  • BIOLARGO, INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $4,659,000, a 18% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

BIOLARGO, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $8,221,000 +$3,783,000 +85% 01 Jan 2025 31 Dec 2025 10-K 04 Mar 2026 2025 FY
2024 $4,438,000 -$221,000 -4.7% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2026 2025 FY
2023 $4,659,000 +$703,000 +18% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $3,956,000 -$275,000 -6.5% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024 2023 FY
2021 $4,231,000 -$109,000 -2.5% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023 2022 FY
2020 $4,340,000 -$126,000 -2.8% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022 2021 FY
2019 $4,466,000 +$824,000 +23% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021 2020 FY
2018 $3,642,000 +$269,000 +8% 01 Jan 2018 31 Dec 2018 10-K 31 Mar 2020 2019 FY
2017 $3,373,000 -$598,009 -15% 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019 2018 FY
2016 $3,971,009 +$438,446 +12% 01 Jan 2016 31 Dec 2016 10-K 16 Mar 2018 2017 FY
2015 $3,532,563 +$1,751,919 +98% 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2016 2015 FY
2014 $1,780,644 +$627,144 +54% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016 2015 FY
2013 $1,153,500 -$901,995 -44% 01 Jan 2013 31 Dec 2013 10-K 31 Mar 2015 2014 FY
2012 $2,055,495 +$632,002 +44% 01 Jan 2012 31 Dec 2012 10-K 01 Apr 2014 2013 FY
2011 $1,423,493 -$162,782 -10% 01 Jan 2011 31 Dec 2011 10-K 29 Mar 2013 2012 FY
2010 $1,586,275 01 Jan 2010 31 Dec 2010 10-K 06 Apr 2012 2011 FY

BIOLARGO, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $866,000 -$217,000 -20% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q1 2024 $1,083,000 -$427,000 -28% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q1 2023 $1,510,000 +$318,000 +27% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q1 2022 $1,192,000 -$290,000 -20% 01 Jan 2022 31 Mar 2022 10-Q 17 May 2023 2023 Q1
Q1 2021 $1,482,000 +$556,000 +60% 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q1 2020 $926,000 +$196,000 +27% 01 Jan 2020 31 Mar 2020 10-Q 17 May 2021 2021 Q1
Q1 2019 $730,000 -$208,000 -22% 01 Jan 2019 31 Mar 2019 10-Q 19 May 2020 2020 Q1
Q1 2018 $938,000 +$485,000 +107% 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019 2019 Q1
Q1 2017 $453,000 +$198,000 +78% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018 2018 Q1
Q1 2016 $255,000 -$92,487 -27% 01 Jan 2016 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q1 2015 $347,487 -$480,013 -58% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016 2016 Q1
Q1 2014 $827,500 +$422,500 +104% 01 Jan 2014 31 Mar 2014 10-Q 15 May 2015 2015 Q1
Q1 2013 $405,000 -$156,094 -28% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014 2014 Q1
Q1 2012 $561,094 -$76,426 -12% 01 Jan 2012 31 Mar 2012 10-Q 15 May 2013 2013 Q1
Q1 2011 $637,520 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.